(Q41052790)

26 September 2017

title

Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection (English)

1 reference

26 September 2017

3

Ascher NL

1 reference

26 September 2017

Kang SM

1

1 reference

26 September 2017

Lin Z

series ordinal

2

1 reference

26 September 2017

Stock PG

series ordinal

4

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

Transplantation Proceedings

26 September 2017

published in

1 reference

26 September 2017

volume

30

1 reference

26 September 2017

issue

2

1 reference

26 September 2017

page(s)

538

1 reference

Fas ligand and immune evasion

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2901396-1

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2901396-1

7 January 2021

A role for CD95 ligand in preventing graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2901396-1

7 January 2021

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2901396-1

7 January 2021

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2901396-1

7 January 2021

Immune response and myoblasts that express Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2901396-1

7 January 2021

10.1016/S0041-1345(97)01396-1

Identifiers

DOI

1 reference

26 September 2017

1 reference